日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML

多选择性 RAS(ON) 抑制剂靶向致癌 RAS,并克服急性髓系白血病 (AML) 中 RAS 介导的对 FLT3 抑制剂和 BCL2 抑制剂的耐药性。

Popescu, Bogdan; Jones, Matthew F; Piao, Madison; Tran, Elaine; Koh, Andrew; Lomeli, Isabelle; Peretz, Cheryl A C; Murad, Natalia; Abelson, Sydney; Morales, Carolina; Rivera, Jose M; Batingana, Alexa Rane; D'Souza, Jeevitha; Pikman, Yana; Cheng, Michael L; Logan, Aaron C; Huang, Benjamin J; Stieglitz, Elliot; Smith, Catherine C

Blood-based epigenetic instability linked to human aging and disease

血液中表观遗传不稳定性与人类衰老和疾病相关

Basrai, Salman; Nofech-Mozes, Ido; Detroja, Rajesh; Scolari, Fernando L; Bakhtiari, Mehran; Arruda, Andrea; Murphy, Tracy; Bratman, Scott V; Chan, Steven M; Minden, Mark D; Sook Ahn, Jae; Kim, Dennis D H; Kridel, Robert; Billia, Filio; Abelson, Sagi

Real World Human-LLM Interactions - Prospective blinded versus unblinded expert physician assessments of LLM responses to complex medical dilemmas

真实世界中人机交互——前瞻性盲法与非盲法专家医师对LLM应对复杂医疗难题的反应评估

Ben Shitrit, Itamar; Idan, Daphna; Volevich, Mark; Goldenberg, Hadar Sharabi; Vaknin, Dolev; Degany, Or; Abelson, Nitzan; Binyamin, Yair; Nassar, Raouf; Nassar, Majd; Kedmi, Aviya; Zlotnik, Alexander; Einav, Sharon

The role of the flexible loop region in the substrate binding and catalytic activity of malate dehydrogenases

柔性环区在苹果酸脱氢酶底物结合和催化活性中的作用

Jamburuthugoda, Varuni K; Berndsen, Christopher E; Zhang, Jing; Bell, Jessica K; Cheung-Tung, Wai; Maskovsky, Daniel; Kester, Kayla; Abelson, Tina; Huynh, Ethan; Bell, John Ellis

FLT3 is genetically essential for ITD-mutated leukemic stem cells but dispensable for human hematopoietic stem cells

FLT3对于ITD突变的白血病干细胞而言是基因必需的,但对于人类造血干细胞而言则并非必需。

Araújo, Joana L; Wagenblast, Elvin; Voisin, Veronique; McLeod, Jessica; Gan, Olga I; Bansal, Suraj; Jin, Liqing; Mitchell, Amanda; Gratton, Blaise; Cutting, Sarah; Arruda, Andrea; Doedens, Monica; Travas, Anthea; Kim, Dennis; Capo-Chichi, Jose-Mario; Abelson, Sagi; Minden, Mark D; Wang, Jean C Y; Sobrinho-Simões, Manuel A; Pinto-do-Ó, Perpétua; Lechman, Eric; Dick, John E

Cellular immunotherapy targeting CLL-1 for juvenile myelomonocytic leukemia

针对 CLL-1 的细胞免疫疗法治疗幼年型骨髓单核细胞白血病

Juwita Werner # ,Alex G Lee # ,Chujing Zhang ,Sydney Abelson ,Sherin Xirenayi ,Jose Rivera ,Khadija Yousuf ,Hanna Shin ,Bonell Patiño-Escobar ,Stefanie Bachl ,Kamal Mandal ,Abhilash Barpanda ,Emilio Ramos ,Adila Izgutdina ,Sibapriya Chaudhuri ,William C Temple ,Shubhmita Bhatnagar ,Jackson K Dardis ,Julia Meyer ,Carolina Morales ,Soheil Meshinchi ,Mignon L Loh ,Benjamin Braun ,Sarah K Tasian ,Arun P Wiita ,Elliot Stieglitz

Antibodies targeting Crimean-Congo hemorrhagic fever virus GP38 limit vascular leak and viral spread

针对克里米亚-刚果出血热病毒GP38的抗体可限制血管渗漏和病毒传播。

Pahmeier, Felix; Monticelli, Stephanie R; Feng, Xinyi; Hjorth, Christy K; Wang, Albert; Kuehne, Ana I; Bakken, Russell R; Batchelor, Thomas G; Lee, Saeyoung E; Middlecamp, Marissa; Stuart, Lauren; Duarte-Neto, Amaro N; Abelson, Dafna M; McLellan, Jason S; Biering, Scott B; Herbert, Andrew S; Chandran, Kartik; Harris, Eva

The many NO's to the use of class I antiarrhythmics: does this also apply to ethacizinum?

针对 I 类抗心律失常药物的诸多禁忌:这是否也适用于依他西嗪?

Abelson, John; Sokolova, E; Ainars Rudzitis, P H D; Oskars Kalejs, P H D; Aivars Lejnieks, P H D

Mimicking sMMOH chemistry: trapping the Sc(3+)-bound nonheme Fe(III)-O-O-Fe(III) adduct prior to its conversion into an Fe(IV) (2)(μ-O)(2) core

模拟 sMMOH 化学:在 Sc(3+) 结合的非血红素 Fe(III)-OO-Fe(III) 加合物转化为 Fe(IV) (2)(μ-O)2 核心之前将其捕获

Crossland, Patrick M; Chandra, Bittu; Banerjee, Saikat; Abelson, Chase S; Guo, Yisong; Swart, Marcel; Que, Lawrence

Change Is Hardest Right Before the Glass Ceiling Breaks: An Update on Women Pursuing Careers in Academic Surgery at a National Level

变革最难的时刻往往就在打破玻璃天花板之前:全国范围内女性在学术外科领域追求职业发展的最新进展

Harris, Haley; Tan, Isabelle; Qiu, Yuqing; Brouwer, Julianna; Abelson, Jonathan; Sosa, Julie Ann; Yeo, Heather